F-nanoparticles: Platform for in vivo delivery of fluorinated biomaterials for F-MRI.

J Control Release

Translational Nanobiomaterials and Imaging (TNI) Group, Department of Radiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA Leiden, the Netherlands. Electronic address:

Published: October 2021

Fluorine-19 (F) magnetic resonance imaging (MRI) features one of the most investigated and innovative techniques for quantitative and unambiguous cell tracking, providing information for both localization and number of cells. Because of the relative insensitivity of the MRI technique, a high number of magnetically equivalent fluorine atoms are required to gain detectable signals. However, an increased amount of F nuclei induces low solubility in aqueous solutions, making fluorine-based probes not suitable for in vivo imaging applications. In this context, nanoparticle-based platforms play a crucial role, since nanoparticles may carry a high payload of F-based contrast agents into the relevant cells or tissues, increase the imaging agents biocompatibility, and provide a highly versatile platform. In this review, we present an overview of the F-based nanoprobes for sensitive F-MRI, focusing on the main nanotechnologies employed to date, such as fluorine and theranostic nanovectors, including their design and applications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2021.09.001DOI Listing

Publication Analysis

Top Keywords

f-nanoparticles platform
4
platform vivo
4
vivo delivery
4
delivery fluorinated
4
fluorinated biomaterials
4
biomaterials f-mri
4
f-mri fluorine-19
4
fluorine-19 magnetic
4
magnetic resonance
4
resonance imaging
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!